GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
8FLY | 8FLY | HIV-1 gp120 complex with BNM-III-170 | |
5F4P | 5F4P | HIV-1 gp120 complex with BNM-III-170 | |
2NXY | Q49DS8 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
2NXY | P01730 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
2NXY | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
2NXY | Q6N095 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
2NY7 | P04578 | HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 | |
2NY7 | 2NY7 | HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 | |
2NXZ | Q8QDX5 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXZ | P01730 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXZ | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXZ | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY2 | Q993A8 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY2 | P01730 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY2 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY2 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY0 | Q8QDX5 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY0 | P01730 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY0 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY0 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | P01730 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | Q71057 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY6 | Q8Q7Z9 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY6 | P01730 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY6 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY6 | Q6N030 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY4 | Q8QDX5 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | P01730 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | Q993A8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | P01730 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | Q6N030 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY1 | Q993A8 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY1 | P01730 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY1 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY1 | Q6N030 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
6UDK | S6B2B6 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | S6B2B6 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q8N355 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q8N355 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | S6C4S0 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | S6C4S0 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q6PJF2 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q6PJF2 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024